Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of generic edoxaban 60 mg (INNOXABAN) vs LIXIANA in healthy Thai volunteers under fasting conditions
TCTR20250228003Phase 1Not yet recruiting
- Sponsor
- International Bio Service
- Start
- Sep 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of edoxaban (2 arms), sponsored by International Bio Service. Planned start Sep 2025; status: not yet recruiting.
02
Drugs
edoxaban
Beyond the preview
Go deeper on TCTR20250228003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20250228003.